Search

for
Search:

GlossaryPolyscias scutellaria

tropical evergreen shrub known as Shield Aralia

Polyscias scutellaria, also known as Shield Aralia or Balfour Aralia, is a tropical evergreen shrub or small tree commonly used as an ornamental plant. It features rounded, glossy leaves and can be grown indoors or outdoors in warm climates. While primarily valued for its aesthetic appeal, it is also known for its air-purifying qualities.

Related Terms

Sort by

Community Join

30 / 1000+ results

community CASSIOPEA ANNOUNCES VERY POSITIVE PHASE II TWELVE MONTHS RESULTS FOR BREEZULA® (CLASCOTERONE) IN TREATING ANDROGENETIC ALOPECIA

in Update 163 upvotes 7 years ago

Clascoterone (Breezula) showed positive results for treating hair loss without affecting cortisol levels. Opinions vary, with some users optimistic about its potential and others critical of its effectiveness compared to existing treatments like finasteride.

community Cassiopea Announces Very Positive Interim Analysis Phase 2 Results for Breezula® (Clascoterone) in Treating Androgenetic Alopecia

62 upvotes 7 years ago

Breezula® (Clascoterone) showed promising results in a Phase 2 trial for treating hair loss, being as effective as Propecia with no serious side effects. It might be released between 2021-2022, and a related acne treatment with the same active ingredient could be used in the meantime.

community Clascoterone for hair loss. Promising study.

in Treatment 12 upvotes 6 months ago

A new topical medication, Clascoterone, shows promise for hair loss, improving hair count significantly. Trials for Breezula are ending, but sign-ups for PP405 trials are available for 2026.

community Clascoterone - what we have right now

in Research/Science 23 upvotes 3 months ago

Clascoterone is a topical treatment for androgenetic alopecia, showing modest to moderate hair regrowth, and may be available by 2027-2028. It is considered safer than finasteride, with discussions on its effectiveness compared to RU58841 and pyrilutamide.

community clascoterone powder to topical diy

in Product 3 upvotes 1 month ago

The conversation is about making a topical solution from clascoterone powder, with references to using a RU58841 mixing guide for guidance. Concerns about product authenticity and bulk purchase requirements are also discussed.

community Clascoterone study going on right now

in Research/Science 355 upvotes 2 years ago

A user is participating in a phase 3 trial for Clascoterone, a topical acne medication that may stimulate hair growth, and will share results after 6 months. They will have a section of their hair shaved and marked with a tattoo for the study.

community Clascoterone full results in July

in Research/Science 13 upvotes 1 month ago

Clascoterone's full trial results are expected by mid-July 2026, but skepticism exists about timely release. Clascoterone is available at 5% from some telehealth companies.

community SCUBE3/Pyr/or anything else of interest in the piplines. any updates?

in Research/Science 10 upvotes 3 years ago

Hair loss treatments discussed include promising Pyr available online and Verteporfin dosing after FUE for follicle regeneration, but no updates on SCUBE3.

community Brief update clascoterone phase 3 - Breezula

in Research/Science 4 upvotes 2 years ago

Cosmo Pharmaceuticals has enrolled about 850 out of 1400 patients for their phase 3 clinical trials of clascoterone (Breezula) and claims to be on schedule. The conversation is about hair loss treatments.

community SCUBE3 IS A GO! Clinical trials planned for later this year

in Research/Science 99 upvotes 3 years ago

SCUBE3 clinical trials for hair loss treatment to start this year. Treatment may involve regular, painless scalp injections to maintain hair growth.

community Anyone heard of scube3? And other emerging treatments?

in Research/Science 4 upvotes 1 year ago

Emerging hair loss treatments like PP405, a topical MPC inhibitor, show promise in activating stem cells for hair growth. The conversation seeks information on the development stages and accessibility of these treatments.

community Spiro for AGA in Europe

5 upvotes 6 years ago

Treatment options for female alopecia androgenetica, discussing the availability of spironolactone online in The Netherlands and other potential treatments like finasteride, minoxidil and RU58841.

community Breezula is a good alternative

in Research/Science 5 upvotes 1 month ago

Clascoterone 5% solution (Breezula) is a promising alternative for androgenetic alopecia, showing continued hair growth with consistent use and no significant side effects. It may be suitable for those who cannot tolerate finasteride or dutasteride, especially when trying to conceive.

community Expectations control for SCUBE3

in Research/Science 22 upvotes 2 years ago

SCUBE3, a protein linked to hair growth in moles, was discovered over 25 years ago and is being developed by Amplifica for potential hair loss treatment. Concerns exist about SCUBE3's association with cancer, as it is a protein that promotes cell growth, which could potentially trigger cancer development if used for hair growth therapy.

community SCUBE3 is going to save us!!! This is the news we've all been waiting for...

in Research/Science 92 upvotes 3 years ago

User discusses potential hair loss treatment SCUBE3 and shares mixed opinions on its effectiveness. One user reports positive results after applying SCUBE3 following microneedling.

community Clascoterone ph3 results ready

in Research/Science 9 upvotes 6 months ago

Clascoterone 5% solution showed a 539% improvement in hair count compared to placebo, but the actual increase in hair growth is minimal. Users express skepticism about the effectiveness of hair loss treatments.

community Capilia Longa and scandinavian biolabs

in Research/Science 2 upvotes 3 years ago

Capilia Longa and Scandinavian Biolabs are discussed, with skepticism about their effectiveness and value. The conversation suggests avoiding these products due to high cost and perceived lack of results.

community Does SCUBE3 have the potential to regrow a juvenile hairline?

in Treatment 2 upvotes 2 years ago

The conversation is about the potential of SCUBE3 to regrow a juvenile hairline. Specific treatments mentioned include Minoxidil, Finasteride, and RU58841.

community Cassiopea claims CB results equal to fin - does this check out?

in Research/Science 6 upvotes 5 years ago

Cassiopea claimed that their hair loss treatment, Clascoterone, shows comparable results to finasteride after six months of use. Some users believe Clascoterone could be an additional treatment option for those who do not respond to finasteride.

community Clascoterone - Why are there so few posts if it’s already on the market?

in Chat 34 upvotes 4 months ago

Clascoterone is being discussed for hair loss, but its current acne formulation may not be suitable for scalp use due to potential skin irritation and lower dosage compared to Breezula. Users mention other treatments like finasteride, minoxidil, and pyrilutamide, with some expressing skepticism about clascoterone's effectiveness for hair loss.

community What are we thinking about this SCUBE3 boys

in Product 7 upvotes 8 months ago

SCUBE3 is a promising new molecule that can restart hair growth by reawakening dormant hair follicles. Users express skepticism about its availability timeline, with some hoping for release by 2026.

community More great news about SCUBE3... this could be it!

in Research/Science 30 upvotes 3 years ago

SCUBE3 is a potential hair loss treatment that people are hopeful about. It may provide a solution without the side effects of finasteride.

community Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results

in Research/Science 369 upvotes 5 months ago

Clascoterone 5% solution shows strong potential for hair growth, offering a new treatment for alopecia with minimal side effects. It blocks androgen receptors locally and may be available by late 2026 or early 2027.

community PCOS female with significant receding and thinning; doctor won’t give me anything but Spiro and Spiro sucks

in Female 5 upvotes 3 years ago

Female with PCOS experiences receding and thinning hair, wants dutasteride instead of spironolactone. Discusses desire to reduce DHT without losing libido.

community Clascoterone powder already available?

in Product 4 upvotes 2 months ago

Clascoterone powder is now available, but it's expensive and not widely discussed due to past ineffective results at higher concentrations. Users are skeptical about its effectiveness and are seeking reliable sources.

community Clascoterone/ Breezula will it work

in Research/Science 2 months ago

Breezula's effectiveness is uncertain, with some users skeptical about its potential and others noting its recent availability on the grey market. A user reported success with a stack of Dutasteride (oral), Minoxidil (topical), and RU58841 (topical), achieving significant hair improvement after 18 months.

community Scarring Alopecia and NSAIDs?

in Female 4 upvotes 5 years ago

The user suspects scarring alopecia and is exploring NSAIDs and turmeric/pepper for inflammation-related hair loss, having experienced burning and thinning with finasteride and testosterone reduction. They are seeking feedback while unable to afford a dermatologist.

community SCUBE 3 (the last hair bender)

in Research/Science 2 upvotes 11 months ago

SCUBE3 and Amplifica's progress in hair loss treatment is being discussed, with inquiries about their current status and clinical trials. No specific updates or new information are provided in the conversation.

community Breezula Phase III 12-Month Data Released by Cosmo Pharma

in Research/Science 39 upvotes 2 months ago

Clascoterone 5% topical solution is effective and safe for long-term use in treating male pattern hair loss. Cosmo Pharma aims for EU and US approval, with a potential US release in late 2027 or early 2028.

community Clascoterone phase 3 results are out!

in Treatment 83 upvotes 6 months ago

Clascoterone phase 3 results show promising improvements in hair count, but concerns about high costs and lack of detailed data remain. Users compare it to existing treatments like Minoxidil and Finasteride, expressing skepticism about its accessibility and effectiveness.